Mankind Pharma Limited

Equities

MANKIND

INE634S01028

Market Closed - NSE India S.E. Other stock markets 05:19:41 17/12/2025 pm IST			5-day change	1st Jan Change
2,111.20 ^INR	+0.25%		-1.75%	-26.70%

10/12	Mankind Pharma receives tax penalty of 153.2 million rupees	RE
01/12	EQT Shows Interest in Vitabiotics - ET	FW

Transcript : Mankind Pharma Limited, Q4 2025 Earnings Call, May 21, 2025

Published on 05/21/2025 at 09:08 pm IST - Modified on 05/27/2025 at 02:21 am IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, good day, and welcome to the Mankind Pharma Limited Q4 and FY '25 Earnings Conference Call. [Operator Instructions] Please note

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Mankind Pharma Limited

10/12	Mankind Pharma receives tax penalty of 153.2 million rupees	RE
01/12	EQT Shows Interest in Vitabiotics - ET	FW
07/11	India's Torrent Pharma posts profit boost on strong demand for chronic illness drugs	RE
07/11	Jefferies Adjusts Mankind Pharma's Price Target to INR3,000 From INR3,100, Keeps at Buy	MT
07/11	India stock benchmarks may open flat as profit-taking to offset trade optimism	RE
06/11	Bliss GVS Pharma Limited Appoints Shreekrushna Joshi as Head - Legal as Senior Management Personnel, Effective November 6, 2025	CI
06/11	Mankind Pharma Limited, Q2 2026 Earnings Call, Nov 06, 2025
06/11	Mankind Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
06/11	Mankind Pharma posts fourth straight quarterly profit fall on sales hit from tax cuts	RE
06/11	Mankind Pharma Q2 consol net profit 5.12 billion rupees	RE
10/10	Mankind Pharma says business transfer agreement between co, Bharat Serums & Vaccines	RE
04/09	Reactions after India cuts consumption tax on hundreds of items	RE
04/09	Reactions after India cuts consumption tax on hundreds of items	RE
19/08	Mankind Pharma Limited Announces Incorporation of Wholly Owned Subsidiary Company in Russia	CI
19/08	Mankind Pharma says wholly owned subsidiary has been incorporated in Russia	RE
03/09	Mankind Pharma Limited - Shareholder/Analyst Call
04/08	Jefferies Adjusts Mankind Pharma's Price Target to INR3,100 From INR3,000, Keeps at Buy	MT
01/08	Mankind Pharma Limited, Q1 2026 Earnings Call, Aug 01, 2025
31/07	Mankind Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
31/07	India's Mankind Pharma posts lower quarterly profit as costs surge	RE
31/07	Mankind Pharma Q1 consol net profit 4.38 billion rupees	RE
31/07	Mankind Pharma Limited Announces Resignation of Dr. Sanjay Koul, Chief Marketing Officer, Effective August 1, 2025	CI
31/07	Mankind Pharma Limited Approves Interim Dividend for the Financial Year 2025-26	CI
24/07	Mankind Pharma Incorporates Subsidiary in Sri Lanka	MT
24/07	Mankind Pharma incorporates wholly owned subsidiary in Sri Lanka	RE